Hemophilia
Bleeding-FDA Approves Product to Treat Common Bleeding Disorder
...approved Humate-P (Antihemophilic Factor/von Willebrand Factor Complex) for the prevention of excessive bleeding during and after surgery in certain patients with mild to moderate and severe von Willebrand disease
Date:
04/27/2007
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01619.html
FDA Clears Baxter's Modified Infusion Pump
Pump was subject of recalls and seizure actions in 2005
Date:
02/27/2007
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01571.html
Von Willebrand Disease-FDA Approves New Product to Treat Von Willebrand Disease
Alphanate is the first biologic product approved for treatment of surgical and invasive procedures in patients with vWD
Date:
02/02/2007
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01553.html
VTE standards get first public test
The list of major hospital killers is due for a shake-up. Proposed performance...
Date:
03/01/2006
, Publication:
Drug Topics
, Author:
Fred Gebhart
http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=310323
Arterial Diseases
Diseases of the arteries caused 38,748 deaths in 2001...
Date:
02/20/2006
, Publication:
US Publication
, Author:
Somnath Pal, BS (Pharm), MBA, PhD
http://www.uspharmacist.com/index.asp?show=article&page=8_1675.htm
New Drug may reduce need for transfusions in MDS
"Revlimid is an analog of thalidomide that is more potent but less toxic," said Thomas...
Date:
02/06/2006
, Publication:
Drug Topics
, Author:
Heidi Belden, Pharm.D.
http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=302226
New drug approved to treat hyponatremia
A new drug, conivaptan HCl (Vaprisol, Astellas Pharma), has just received approval for treating...
Date:
02/06/2006
, Publication:
Drug Topics
, Author:
Kelly Dowhower Karpa, Ph.D., R. Ph.
http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=302222
Women with AF at Greater Risk of Clots Than Men
Among patients with atrial fibrillation (AF) who are not currently taking the anticoagulant drug warfarin...
Date:
12/01/2005
, Publication:
Pharmacy Times
, Author:
Unavailable
http://www.pharmacytimes.com/Article.cfm?Menu=1&ID=2921
Does Recombinant t-PA Have a Role in AIS?
An estimated 700,000 patients experience a new or recurrent stroke each year. Approximately 500,000 of...
Date:
12/01/2005
, Publication:
Pharmacy Times
, Author:
Phillip S. Owen, PharmD, and Robert Lee Page II, PharmD, FASCP, BCPS
http://www.pharmacytimes.com/Article.cfm?Menu=1&ID=2898
OSA Threatens Arteries
A Brazilian study found that some healthy middle-aged individuals with obstructive sleep apnea (OSA)...
Date:
11/01/2005
, Publication:
Pharmacy Times
, Author:
Unavailable
http://www.pharmacytimes.com/Article.cfm?Menu=1&ID=2823
< Previous
Page 2 of 4
Next >
Search returned 33 items.
|
Sponsored Links
Clinical Researchers, others from
subscriber lists and assoc's.
www.biotechmedia.com
Reach these Drug Developers
Via Email or Mail List Rentals
www.biotechmedia.com
This twice-monthly news magazine
reports on all phases of pharmacy
www.drugtopics.com
This is a "how to" magazine
for pediatric clinicians
www.contemporarypediatrics.com
|